Drospirenone

Drospirenone

Structural formula of Drospirenone

Drospirenone is a synthetic steroid hormone with both progestin and antimineralocorticoid properties, used primarily in birth control pills and hormone replacement therapy. Chemically, it is a spironolactone analogue.

Overview

Drospirenone is known for its role in oral contraceptives like Yasmin and Yaz, where it is combined with ethinylestradiol. It functions by inhibiting ovulation and causing changes in the cervical and uterine lining, making it harder for sperm to reach the uterus and for a fertilized egg to attach to the uterus.

Pharmacology

Mechanism of Action

As a progestin, Drospirenone binds to and activates progesterone receptors in target tissues, exerting a progestational effect. It also exhibits anti-mineralocorticoid activity, working against aldosterone, which can reduce water retention and decrease blood pressure.

Benefits and Risks

• Benefits:

 * Effective in preventing pregnancy
 * Can reduce premenstrual dysphoric disorder (PMDD) symptoms
 * May improve acne and hirsutism in some women

• Risks:

 * Potential for increased risk of blood clots
 * May cause changes in menstrual periods
 * Can lead to increased potassium levels, affecting kidney function

Clinical Uses

Drospirenone is primarily used in:

• Contraception
• Treatment of moderate acne in women seeking oral contraception
• Management of symptoms of premenstrual dysphoric disorder

Side Effects

Common side effects include nausea, headache, breast tenderness, and menstrual irregularities. Less common but more severe side effects include blood clots, high potassium levels, and gallbladder disease.

History and Development

Drospirenone was developed in the 1970s and 1980s as a part of efforts to create progestins with additional beneficial effects like anti-mineralocorticoid activity. It was first approved for use in the United States in 2001.

References

This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia